Skip to main content

CB8025-21845 entitled "A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of Seladelpar Administered for 24 Weeks in Adult Patients with Primary Sclerosing Cholangitis

Research Grant
Duke Scholars

Administered By

Radiology, Abdominal Imaging

Awarded By

CymaBay Therapeutics

Start Date

August 1, 2019

End Date

December 6, 2019
 

Administered By

Radiology, Abdominal Imaging

Awarded By

CymaBay Therapeutics

Start Date

August 1, 2019

End Date

December 6, 2019